KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | Feb 20, 2024 | Sale | $14.07 | 28,288 | 397,929 | 82,048 | Feb 21, 2024, 09:51 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Feb 20, 2024 | Sale | $14.11 | 12,053 | 170,124 | 72,895 | Feb 21, 2024, 09:48 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO | Feb 20, 2024 | Sale | $14.11 | 22,802 | 321,846 | 187,315 | Feb 21, 2024, 09:46 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | CHIEF MEDICAL OFFICER | Feb 20, 2024 | Sale | $14.11 | 14,295 | 201,774 | 52,886 | Feb 21, 2024, 09:44 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Feb 20, 2024 | Sale | $14.11 | 24,888 | 351,289 | 211,203 | Feb 21, 2024, 09:41 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO | Feb 14, 2024 | Sale | $15.01 | 40,855 | 613,205 | 159,088 | Feb 16, 2024, 04:21 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Feb 14, 2024 | Sale | $15.01 | 58,356 | 875,883 | 181,676 | Feb 16, 2024, 04:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | Feb 14, 2024 | Sale | $15.01 | 28,171 | 422,827 | 71,657 | Feb 16, 2024, 04:19 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | CHIEF DEVELOPMENT OFFICER | Feb 14, 2024 | Sale | $15.01 | 39,886 | 598,661 | 66,160 | Feb 16, 2024, 04:18 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | Feb 06, 2024 | Buy | $14.74 | 4,474 | 65,947 | 4,743,157 | Feb 08, 2024, 08:11 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | Feb 07, 2024 | Buy | $14.56 | 51,827 | 754,601 | 4,794,984 | Feb 08, 2024, 08:11 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Feb 08, 2024 | Buy | $14.70 | 29,747 | 437,281 | 4,824,731 | Feb 08, 2024, 08:11 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Feb 01, 2024 | Sale | $16.22 | 10,000 | 162,198 | 118,232 | Feb 05, 2024, 05:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 30, 2024 | Buy | $14.47 | 88,099 | 1,274,793 | 4,738,683 | Feb 01, 2024, 04:38 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 25, 2024 | Buy | $12.73 | 7,030 | 89,492 | 4,565,810 | Jan 29, 2024, 07:07 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | Jan 26, 2024 | Buy | $12.98 | 4,174 | 54,179 | 4,569,984 | Jan 29, 2024, 07:07 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Management EG, LLC | 10% Owner | Jan 29, 2024 | Buy | $14.22 | 80,600 | 1,146,132 | 4,650,584 | Jan 29, 2024, 07:07 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Management III, LLC | 10% Owner | Jan 22, 2024 | Buy | $12.55 | 67,546 | 847,702 | 4,527,197 | Jan 24, 2024, 08:24 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | Jan 23, 2024 | Buy | $12.54 | 10,897 | 136,648 | 4,538,094 | Jan 24, 2024, 08:24 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 24, 2024 | Buy | $12.44 | 20,686 | 257,334 | 4,558,780 | Jan 24, 2024, 08:24 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Co-Investment Holdings III, LLC | 10% Owner | Jan 17, 2024 | Buy | $12.60 | 78,925 | 994,455 | 4,394,971 | Jan 19, 2024, 06:02 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Management III, LLC | 10% Owner | Jan 18, 2024 | Buy | $12.51 | 39,680 | 496,397 | 4,434,651 | Jan 19, 2024, 06:02 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 19, 2024 | Buy | $12.43 | 25,000 | 310,750 | 4,459,651 | Jan 19, 2024, 06:02 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Management III, LLC | 10% Owner | Jan 11, 2024 | Buy | $12.68 | 6,647 | 84,284 | 4,296,447 | Jan 16, 2024, 07:04 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 16, 2024 | Buy | $12.73 | 19,599 | 249,495 | 4,316,046 | Jan 16, 2024, 07:04 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Jan 11, 2024 | Sale | $13.03 | 22,679 | 295,514 | 39,828 | Jan 12, 2024, 04:26 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Koh Bong Y | 10% Owner | Jan 08, 2024 | Buy | $12.44 | 69,184 | 860,649 | 4,221,284 | Jan 10, 2024, 08:57 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Management III, LLC | 10% Owner | Jan 09, 2024 | Buy | $12.56 | 20,816 | 261,449 | 4,242,100 | Jan 10, 2024, 08:57 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 10, 2024 | Buy | $12.67 | 47,700 | 604,359 | 4,289,800 | Jan 10, 2024, 08:57 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Jan 09, 2024 | Sale | $13.00 | 100 | 1,300 | 62,507 | Jan 10, 2024, 06:05 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Jan 08, 2024 | Sale | $13.01 | 17,221 | 224,000 | 62,607 | Jan 10, 2024, 06:05 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Jan 03, 2024 | Buy | $12.20 | 17,605 | 214,781 | 4,110,336 | Jan 05, 2024, 04:13 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Co-Investment Holdings III, LLC | 10% Owner | Jan 04, 2024 | Buy | $12.11 | 41,764 | 505,762 | 4,152,100 | Jan 05, 2024, 04:13 PM |
KALV | | KalVista Pharmaceuticals, Inc. | VHCP Management III, LLC | 10% Owner | Dec 27, 2023 | Buy | $11.97 | 41,514 | 496,923 | 3,615,228 | Dec 29, 2023, 06:44 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Shah Nimish P | 10% Owner | Dec 28, 2023 | Buy | $12.50 | 471,490 | 5,893,625 | 4,086,718 | Dec 29, 2023, 06:44 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners EG, L.P. | 10% Owner | Dec 29, 2023 | Buy | $12.49 | 6,013 | 75,102 | 4,092,731 | Dec 29, 2023, 06:44 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Dec 27, 2023 | Sale | $12.02 | 30,000 | 360,453 | 127,532 | Dec 28, 2023, 04:28 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | Nov 20, 2023 | Sale | $8.23 | 7,985 | 65,711 | 36,568 | Nov 21, 2023, 04:34 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Nov 20, 2023 | Sale | $8.23 | 4,958 | 40,801 | 79,828 | Nov 21, 2023, 04:33 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Nov 20, 2023 | Sale | $8.23 | 7,113 | 58,535 | 46,046 | Nov 21, 2023, 04:32 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | President, CFO, CBO & Sec'y | Nov 20, 2023 | Sale | $8.23 | 13,008 | 107,047 | 112,443 | Nov 21, 2023, 04:31 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Nov 20, 2023 | Sale | $8.23 | 14,807 | 121,851 | 157,532 | Nov 21, 2023, 04:30 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Cha Albert | Director | Sep 11, 2023 | Option Exercise | $9.00 | 36,000 | 323,870 | 18,000 | Sep 13, 2023, 04:29 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | Aug 18, 2023 | Sale | $10.73 | 8,020 | 86,045 | 26,023 | Aug 21, 2023, 08:09 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Aug 18, 2023 | Sale | $10.73 | 4,976 | 53,386 | 73,289 | Aug 21, 2023, 08:07 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Aug 18, 2023 | Sale | $10.73 | 7,142 | 76,624 | 41,662 | Aug 21, 2023, 08:06 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | President, CFO, CBO & Sec'y | Aug 18, 2023 | Sale | $10.73 | 13,067 | 140,192 | 95,254 | Aug 21, 2023, 08:05 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Aug 18, 2023 | Sale | $10.73 | 14,876 | 159,602 | 146,756 | Aug 21, 2023, 08:05 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | May 18, 2023 | Sale | $10.14 | 2,604 | 26,416 | 37,310 | May 19, 2023, 09:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | President, CFO, CBO & Sec'y | May 18, 2023 | Sale | $10.14 | 4,037 | 40,953 | 78,126 | May 19, 2023, 09:19 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | May 18, 2023 | Sale | $10.14 | 1,786 | 18,118 | 66,771 | May 19, 2023, 09:18 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | May 18, 2023 | Sale | $10.14 | 5,627 | 57,083 | 128,050 | May 19, 2023, 09:17 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | May 18, 2023 | Sale | $10.14 | 2,780 | 28,201 | 13,014 | May 19, 2023, 09:16 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | Feb 17, 2023 | Sale | $7.66 | 3,412 | 26,136 | 9,347 | Feb 23, 2023, 05:44 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Feb 17, 2023 | Sale | $7.66 | 2,228 | 17,066 | 64,352 | Feb 23, 2023, 05:44 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Feb 17, 2023 | Sale | $7.66 | 2,727 | 20,889 | 35,709 | Feb 23, 2023, 05:42 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | President, CFO, CBO & Sec'y | Feb 17, 2023 | Sale | $7.66 | 4,954 | 37,948 | 72,799 | Feb 23, 2023, 05:41 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Feb 17, 2023 | Sale | $7.66 | 6,700 | 51,322 | 120,927 | Feb 23, 2023, 05:40 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Nov 18, 2022 | Sale | $5.44 | 1,139 | 6,196 | 34,232 | Nov 21, 2022, 04:21 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO & Secretary | Nov 18, 2022 | Sale | $5.44 | 722 | 3,928 | 68,390 | Nov 21, 2022, 04:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Nov 18, 2022 | Sale | $5.44 | 530 | 2,883 | 62,376 | Nov 21, 2022, 04:18 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Nov 18, 2022 | Sale | $5.44 | 1,785 | 9,710 | 114,878 | Nov 21, 2022, 04:17 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | Nov 18, 2022 | Sale | $5.44 | 722 | 3,928 | 5,946 | Nov 21, 2022, 04:15 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Sep 02, 2022 | Sale | $17.01 | 1,320 | 22,458 | 110,858 | Sep 07, 2022, 04:50 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Chief Medical Officer | Aug 17, 2022 | Sale | $14.96 | 725 | 10,847 | 1,693 | Aug 19, 2022, 05:24 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Aug 17, 2022 | Sale | $14.96 | 532 | 7,960 | 61,132 | Aug 19, 2022, 05:17 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Aug 17, 2022 | Sale | $14.96 | 1,145 | 17,130 | 33,597 | Aug 19, 2022, 05:16 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO & Secretary | Aug 17, 2022 | Sale | $14.96 | 725 | 10,847 | 66,693 | Aug 19, 2022, 05:15 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Aug 17, 2022 | Sale | $14.96 | 1,797 | 26,890 | 112,178 | Aug 19, 2022, 04:58 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Mar 09, 2022 | Sale | $17.07 | 10,000 | 170,693 | 114,670 | Mar 11, 2022, 04:56 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Jan 07, 2022 | Option Exercise | $7.54 | 57,657 | 434,832 | 59,891 | Jan 11, 2022, 04:42 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Nov 01, 2021 | Sale | $18.07 | 6,000 | 108,424 | 2,234 | Nov 03, 2021, 05:00 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Nov 01, 2021 | Sale | $18.07 | 5,000 | 90,328 | 32,969 | Nov 03, 2021, 04:56 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Oct 01, 2021 | Sale | $17.18 | 10,000 | 171,841 | 124,670 | Oct 04, 2021, 04:57 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Aug 02, 2021 | Sale | $20.52 | 5,000 | 102,578 | 37,969 | Aug 04, 2021, 07:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Aug 02, 2021 | Sale | $20.52 | 6,000 | 123,134 | 8,234 | Aug 04, 2021, 07:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Jul 01, 2021 | Sale | $24.15 | 10,000 | 241,477 | 140,320 | Jul 02, 2021, 05:35 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Jun 09, 2021 | Sale | $30.05 | 8,933 | 268,480 | 145,737 | Jun 11, 2021, 07:29 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Smith Michael David | Senior VP, Development | Jun 01, 2021 | Option Exercise | $17.61 | 15,000 | 264,146 | 7,500 | Jun 03, 2021, 06:28 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Jun 01, 2021 | Sale | $26.81 | 25,800 | 691,665 | 22,448 | Jun 03, 2021, 06:26 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Jun 02, 2021 | Sale | $26.43 | 8,200 | 216,696 | 15,296 | Jun 03, 2021, 06:26 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | May 03, 2021 | Sale | $17.53 | 12,000 | 210,311 | 60,234 | May 06, 2021, 08:03 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Smith Michael David | Senior VP, Development | Apr 28, 2021 | Sale | $17.08 | 20,028 | 342,000 | 10,014 | Apr 30, 2021, 05:49 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Maetzel Andreas | Senior Vice President, Medical | Apr 27, 2021 | Sale | $16.85 | 22,034 | 371,307 | 11,017 | Apr 29, 2021, 08:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Maetzel Andreas | Senior Vice President, Medical | Apr 28, 2021 | Sale | $16.66 | 72,254 | 1,203,749 | 36,127 | Apr 29, 2021, 08:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Maetzel Andreas | Senior Vice President, Medical | Apr 29, 2021 | Sale | $17.86 | 81,772 | 1,460,613 | 40,886 | Apr 29, 2021, 08:55 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Apr 01, 2021 | Sale | $27.44 | 10,000 | 274,436 | 168,720 | Apr 05, 2021, 06:38 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Feb 23, 2021 | Sale | $33.59 | 15,000 | 503,877 | 62,169 | Feb 25, 2021, 08:25 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO & Secretary | Feb 23, 2021 | Sale | $20.16 | 59,284 | 1,195,349 | 94,642 | Feb 25, 2021, 08:23 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Feb 23, 2021 | Sale | $33.60 | 31,000 | 1,041,642 | 83,946 | Feb 25, 2021, 08:22 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Feb 23, 2021 | Sale | $33.55 | 10,000 | 335,538 | 178,920 | Feb 25, 2021, 08:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | Jan 04, 2021 | Sale | $18.19 | 10,000 | 181,904 | 186,234 | Jan 06, 2021, 05:33 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CFO, CBO & Secretary | Dec 30, 2020 | Sale | $13.39 | 716 | 9,588 | 32,858 | Jan 04, 2021, 06:06 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Nov 02, 2020 | Sale | $17.14 | 6,000 | 102,812 | 72,734 | Nov 04, 2020, 05:03 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Cha Albert | Director | Oct 30, 2020 | Buy | $17.24 | 115,686 | 1,994,068 | 1,138,179 | Nov 03, 2020, 07:56 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 29, 2020 | Sale | $17.48 | 5,000 | 87,394 | 62,969 | Nov 02, 2020, 08:01 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 20, 2020 | Sale | $17.49 | 7,942 | 138,886 | 76,315 | Oct 22, 2020, 05:36 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | Oct 21, 2020 | Sale | $18.25 | 6,044 | 110,282 | 70,513 | Oct 22, 2020, 05:36 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Oct 20, 2020 | Sale | $17.48 | 7,900 | 138,090 | 90,041 | Oct 22, 2020, 05:34 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | Oct 21, 2020 | Sale | $18.31 | 9,007 | 164,928 | 84,141 | Oct 22, 2020, 05:34 PM |